Check out the latest publications and poster presentations related to our science.
American Society of Hematology (ASH) Dec. 2019 –Allogeneic Anti-BCMA CAR T Cells Show Tumor Specific Killing Against Primary Multiple Myeloma Cells
American Society of Hematology (ASH) Dec. 2019 – Preclinical Evaluation of ALLO-819, Targeting FLT3, in Acute Myeloid Leukemia
American Association for Cancer Research (AACR) April 2019 – AlloCAR TTM Targeting CD70 For RCC
American Society of Hematology (ASH) Dec. 2018 – ALLO-819, An Allogeneic FLT3 CAR T Therapy Possessing An Off-Switch for the Treatment of Acute Myeloid Leukemia
American Society of Hematology (ASH) Dec. 2018 – UCART19 PALL and CALM Studies
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies Valton J, Guyot V, Boldajipour B, et al.
American Society of Gene and Cell Therapy (ASGCT) May 2018 – Development of an In Vitro Cynomolgus Macaque Allogeneic CAR T Cell Platform
Stay informed about our latest news and developments.
Interested in learning about job opportunities at Allogene?